The Nippon India Large Cap Fund - Growth has an AUM of 41750.19 crores & has delivered CAGR of 26.10% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.53%.

A large-cap stock is a stock with a market capitalization over $10 billion. The best-known companies in the United States all have them — and large-cap stocks make up around 90% of the total U.S ...

Large-caps range from some under-the-radar picks to the household names that everyone knows, such as Amazon, Apple and Microsoft. So, the biggest large-cap companies may be as much as 100 times ...

Abbotsford stabbing victim identified as 15-year-old, suspect still at large By Amy Judd Global News Posted July 6, 2025 2:00 pm 1 min read ...

A large cat is reportedly roaming in the area around the East-West Center on the University of Hawaii at Manoa campus. The Department of Land and Natural Resources said the Division of Conservation ...

Best large SUVs and 4x4s Below, our experts reveal the very best SUVs and 4x4s available, all of which have excelled in our rigorous lab and road tests. Log in now to see which large SUVs and 4x4s we ...

Graph-based clustering technique has garnered significant attention due to precise information characterization by pairwise graph similarity. Nevertheless, the post-processing step in traditional ...

Large Cap Growth Fund II Class R1 Fund 16.45 0.17 1.05% 07/03/2025 12:00 AM NAV Add to watchlist ...

The Tankan Large Manufacturing Index rates the relative level of general business conditions in the manufacturing sector. On the index, a level above zero indicates improving conditions; below ...

To say the global large language model (LLM) market is booming, estimated around $7–8 billion in 2025 and projected to exceed $100 billion by 2030, is an understatement. Businesses and individuals ...

Large & Mid Cap Fund : The fund has 92.11% investment in domestic equities of which 52.04% is in Large Cap stocks, 9.14% is in Mid Cap stocks, 9.14% in Small Cap stocks.The fund has 4.73% ...

The largest observational study of GLP-1 weight-loss drugs suggests their benefits could be wide-ranging, but there are some risks to consider.